Clinical Trial: The Occurrence of the ApoE4 Allele in Agitated In-Patients With Late-Onset Alzheimer's Disease
Study Status: Completed
Recruit Status: Completed
Study Type: Observational
Official Title: The Occurrence of the ApoE4 Allele in Agitated In-Patients With Late-Onset Alzheimer's Disease Compared to Age- and Gender-Matched, Non-Agitated In-Patients With
Brief Summary: The purpose of this clinical research study is to determine if a specific genetic allele is involved with the development of agitation in patients with late-onset Alzheimer's Disease (AD). The study will compare the results of genetic testing between two groups: individuals with late-onset AD who show signs of agitation and individuals with late-onset AD who do not show signs of agitation.
Detailed Summary: Agitation and other behavioral disturbances are a main cause in the need for increasing levels of care for the patient with Alzheimer's disease (AD). And while the pathology of dementia has been studied in great detail, the etiology is considered multi-factorial. The hypothesis behind this clinical study is that the presence of the apo lipoprotein E4 (APO E4) allele will serve to predict which patients with late on-set AD are at greater risk to develop agitation.
Sponsor: Avera McKennan Hospital & University Health Center
Current Primary Outcome: Apolipoprotein E4 Allele [ Time Frame: Single clinic visit (day 1) ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Avera McKennan Hospital & University Health Center
Dates:
Date Received: January 11, 2011
Date Started: December 2010
Date Completion:
Last Updated: October 4, 2011
Last Verified: February 2011